4//SEC Filing
Karyopharm Therapeutics Inc. 4
Accession 0001209191-15-032717
$KPTICIK 0001503802operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 5:35 PM ET
Size
5.1 KB
Accession
0001209191-15-032717
Insider Transaction Report
Form 4
WEG KENNETH E
Director
Transactions
- Award
Common Stock
2015-04-02$29.55/sh+5,000$147,760→ 5,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.41 to $29.99, inclusive. The reporting person undertakes to provide to Karyopharm Therapeutics Inc., any security holder of Karyopharm Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001503802
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 5:35 PM ET
- Size
- 5.1 KB